April 22, 2024

GENESIS 26 ‒ The LIFE SCIENCE TECH DAY

GENESIS 26 ‒ The LIFE SCIENCE TECH DAY
Go back
Thursday, March 12, 2026, WOMEN’S BATH Heidelberg

GENESIS 26 ‒ The LIFE SCIENCE TECH DAY

Engineering Next-Generation Platforms for Disease Modeling and Drug Screening

Inside Heidelberg’s innovation corridor: where innovative industry meets state-of-the-art science — and world-class research universities meet applicable high-tech. The Genesis 26 event creates growth and success with collaboration.
How can disease processes be simulated more realistically and active ingredients tested more quickly, safely, and reproducibly? This question will be the focus of the next LIFE SCIENCE TECH DAY 2026, which will be hosted by our InnovationLab in Heidelberg on Thursday, March 12, 2026, from 9:00 a.m. to 5:00 p.m. 
Flyer Genesis 26 – Agenda
register now

Our latest News

discover more
RHEACELL makes second location in Heidelberg visible

RHEACELL makes second location in Heidelberg visible

Heidelberg, January 28, 2026 – RHEACELL GmbH & Co. KG is continuing to expand its presence in Heidelberg and moved into a second location in the Pfaffengrund district in August last year. At the start of the year, the location is now also becoming visible to the outside world: this week, the company logo will […]

read more
TUM Researchers receive two ERC Grants

TUM Researchers receive two ERC Grants

The European Research Council’s (ERC) Proof of Concept Grants are designed to help researchers turn their findings into real‑world innovations. Two ERC‑funded follow‑up projects at TUM will each receive approximately 150,000 euros in support. The projects focus on virus‑driven cancer treatments and new ways to supply electrons for enzyme‑based technologies. Researchers at TUM have secured […]

read more
Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Cachexia is a metabolic disorder that causes uncontrolled weight loss and muscle wasting in chronic diseases and cancer. A new study by Helmholtz Munich, in collaboration with the Institute of Physiology of the Czech Academy of Sciences in Prague, Heidelberg University Hospital, the German Center for Diabetes Research (DZD), and the German Center for Cardiovascular […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp